Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 1999, p. 3725-3730, Vol. 37, No. 11
Respiratory Diseases Branch, Centers for
Disease Control and Prevention, Atlanta, Georgia
30333,1 and Immunology Laboratory,
Received 7 June 1999/Returned for modification 2 August
1999/Accepted 17 August 1999
To assess pneumococcal strain variability among young asymptomatic
carriers in Chile, we used serotyping, antibiotic susceptibility testing, and genotyping to analyze 68 multidrug-resistant pneumococcal isolates recovered from 54 asymptomatic children 6 to 48 months of age.
The isolates represented capsular serotypes 19F (43 isolates), 14 (14 isolates), 23F (7 isolates), 6B (3 isolates), and 6A (1 isolate).
Genotypic analysis, which included pulsed-field gel electrophoresis
(PFGE) of chromosomal digests, penicillin binding protein (PBP) gene
fingerprinting, and dhf gene fingerprinting, revealed that
the isolates represented six different genetic lineages. Clear
circumstantial evidence of capsular switching was seen within each of
four of the genetically related sets. The majority of the isolates,
consisting of the 43 19F isolates and 2 type 6B isolates, appeared to
represent a genetically highly related set distinct from previously
characterized pneumococcal strains. Each of three other genetically
defined lineages was closely related to one of the previously
characterized clones Spain6B-2, France9V-3, or
Spain23F-1. A fifth lineage was comprised of four type 23F
isolates that, by the techniques used for this study, were genetically
indistinguishable from three recent type 19F sterile-site isolates from
the United States. Finally, a sixth lineage was represented by a single
type 23F isolate which had a unique PFGE type and unique PBP and
dhf gene fingerprints.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genotypic Survey of Recent
-Lactam-Resistant
Pneumococcal Nasopharyngeal Isolates from Asymptomatic Children
in Chile
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, Mailstop C02, 1600 Clifton Rd., NE,
Atlanta, GA 30333. Phone: (404) 639-1237. Fax: (404) 639-3123. E-mail: beb0{at}cdc.gov.
Journal of Clinical Microbiology, November 1999, p. 3725-3730, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|